Skip to content
healthcare.dev

Topiramate

NDC 61919-213, Topiramate, tablet, from C.

Product NDC
61919-213
Status
Listed
Labeler
C
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076343
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61919-213 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE100 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
61919-213-306191902133030 TABLET in 1 BOTTLE (61919-213-30)
61919-213-606191902136060 TABLET in 1 BOTTLE (61919-213-60)
61919-213-7261919021372120 TABLET in 1 BOTTLE (61919-213-72)
61919-213-906191902139090 TABLET in 1 BOTTLE (61919-213-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/164cb1f7-1a41-675f-e063-6294a90ae0dd

Use it

Look up 61919-213 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61919-213 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61919-213. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.